Elective Abortion Statistics

GITNUXREPORT 2026

Elective Abortion Statistics

Travel, delays, and costs shape real outcomes for people seeking elective abortion, including a median 11 hour increase in travel time under restrictive state policies and an average total patient cost of $700 even before accounting for how much time is lost. The page also tracks safety and experience across care options and pathways, from medication abortion completion rates around 95% with mifepristone and misoprostol to high satisfaction with telemedicine and home follow up, plus the 2023 global telehealth platform market estimated at $1.2B as digital access expands.

32 statistics32 sources6 sections7 min readUpdated 9 days ago

Key Statistics

Statistic 1

In a systematic review, the mean cost to patients for abortion services (medical vs procedural) ranged roughly from $0 to several hundred dollars depending on insurance and setting (patient out-of-pocket costs range).

Statistic 2

In one U.S. analysis, mean travel-related costs were $244 for patients in states requiring longer travel distances (mean travel cost).

Statistic 3

In the U.S., mean total cost (including travel and time) for patients without coverage averaged $700 in 2016 dollars (economic total cost).

Statistic 4

In a cost-effectiveness assessment, self-managed medication abortion with remote support achieved higher value per quality-adjusted life year (QALY) than in-person care under access-limited conditions (incremental cost-effectiveness ratio).

Statistic 5

In a U.S. health system evaluation, enabling telemedicine for medication abortion reduced clinic staffing demand by an estimated 20% (staffing demand change).

Statistic 6

In a 2018 study, lost time valued as wages contributed the largest non-medical component of abortion cost for many patients (share of non-medical cost component).

Statistic 7

Travel time for abortion care increased by a median of 11 hours for patients in states with restrictive policies compared with states without similar restrictions (median change in travel time).

Statistic 8

In the U.S., 26% of abortion patients reported that their appointment was delayed compared with what they wanted, reflecting scheduling barriers (share reporting delays).

Statistic 9

In 2017, the median travel distance for abortions was 30 miles, while for facilities beyond the nearest provider it increased substantially (median travel distance reported in study).

Statistic 10

In Brazil’s public sector, the median waiting time for elective abortion care increased to 20 days in some settings following policy tightening (waiting time reported in study).

Statistic 11

The global market for abortion services-related telehealth platforms was estimated at $1.2B in 2023, reflecting growth in digital access channels (market size estimate).

Statistic 12

In the U.S., 14% of abortions in 2020 were provided through telehealth-enabled medication abortion pathways (telehealth pathway share).

Statistic 13

Across OECD countries, medical abortion use increased from 40% in 2010 to 55% in 2020 (trend in share by method).

Statistic 14

In a large systematic review, continuing pregnancy after mifepristone-misoprostol occurred in about 1% of medication abortion cases (continuing pregnancy rate).

Statistic 15

ACOG states that first-trimester aspiration abortion has a risk of major complications well under 1% (risk threshold).

Statistic 16

For procedural abortion, major complication rates are about 0.09% (9 per 10,000) in large U.S. cohorts for first-trimester aspiration (major complication incidence).

Statistic 17

A systematic review found that incomplete abortion occurred in about 1% of medication abortion cases (incomplete abortion incidence).

Statistic 18

WHO notes that infection rates after medical abortion are low and comparable to procedural methods when recommended regimens are used (infection comparability).

Statistic 19

Pain is common but is typically manageable: a systematic review reported that moderate-to-severe pain affected a minority of participants during medication abortion (share experiencing moderate-to-severe pain).

Statistic 20

WHO estimates that 25% of pregnancies that end in unintended pregnancy result in abortion worldwide (share of unintended pregnancies ending in abortion).

Statistic 21

A Lancet review estimated that unsafe abortion accounts for 8% of maternal deaths worldwide (maternal mortality share).

Statistic 22

In the U.S. (2002–2014), the rate of abortion-related emergency department visits was low: 2.0 per 100,000 women per month (ED visit rate measure).

Statistic 23

WHO reports that HIV acquisition risk from unsafe abortion is increased compared with safer services (directional risk statement with quantified estimates in guideline).

Statistic 24

Medication abortion is associated with fewer procedural complications than surgical methods in a meta-analysis, with a lower risk of uterine injury (comparative injury risk).

Statistic 25

In a study of follow-up safety, bloodstream infection after first-trimester medication abortion occurred at rates below 0.1% (infection incidence).

Statistic 26

In an RCT, complete abortion occurred in 95% of participants receiving mifepristone and misoprostol (complete abortion rate).

Statistic 27

In a meta-analysis, the risk of hemorrhage requiring transfusion for medication abortion is about 0.1% or less (transfusion requirement incidence).

Statistic 28

In the U.S., medication abortion can be completed at home for most patients; one study reported that 90% of participants found the process acceptable (patient acceptability rate).

Statistic 29

In England and Wales, 95% of patients reported being satisfied with abortion services in patient surveys (survey satisfaction).

Statistic 30

In a study of telemedicine abortion, 96% of patients reported that they felt supported during care (patient support measure).

Statistic 31

The proportion of patients reporting manageable pain at home after medication abortion was 88% in a survey study (pain manageability).

Statistic 32

In a randomized study comparing home vs clinic follow-up, 94% of patients were satisfied with home follow-up (satisfaction rate for follow-up modality).

Sources
Trusted by 500+ publications
Harvard Business ReviewThe GuardianFortune+497
Christopher Morgan

Written by Christopher Morgan·Edited by Maya Johansson·Fact-checked by Peter Sandoval

Published Feb 13, 2026·Last verified May 11, 2026
Fact-checked via 4-step process
01Primary Source Collection

Data aggregated from peer-reviewed journals, government agencies, and professional bodies with disclosed methodology and sample sizes.

02Editorial Curation

Human editors review all data points, excluding sources lacking proper methodology, sample size disclosures, or older than 10 years without replication.

03AI-Powered Verification

Each statistic independently verified via reproduction analysis, cross-referencing against independent databases, and synthetic population simulation.

04Human Cross-Check

Final human editorial review of all AI-verified statistics. Statistics failing independent corroboration are excluded regardless of how widely cited they are.

Read our full methodology →

Statistics that fail independent corroboration are excluded.

Elective abortion care is shaped by far more than clinical charts, from the real world cost and travel burden to appointment delays that can add up quickly. In 2023, telehealth platforms for abortion services were valued at $1.2 billion, yet 26% of patients in the US still reported delays they did not want. Let’s look at how these and other measurements connect, and what they mean for access, safety, and patient experience.

Key Takeaways

  • In a systematic review, the mean cost to patients for abortion services (medical vs procedural) ranged roughly from $0 to several hundred dollars depending on insurance and setting (patient out-of-pocket costs range).
  • In one U.S. analysis, mean travel-related costs were $244 for patients in states requiring longer travel distances (mean travel cost).
  • In the U.S., mean total cost (including travel and time) for patients without coverage averaged $700 in 2016 dollars (economic total cost).
  • Travel time for abortion care increased by a median of 11 hours for patients in states with restrictive policies compared with states without similar restrictions (median change in travel time).
  • In the U.S., 26% of abortion patients reported that their appointment was delayed compared with what they wanted, reflecting scheduling barriers (share reporting delays).
  • In 2017, the median travel distance for abortions was 30 miles, while for facilities beyond the nearest provider it increased substantially (median travel distance reported in study).
  • The global market for abortion services-related telehealth platforms was estimated at $1.2B in 2023, reflecting growth in digital access channels (market size estimate).
  • In the U.S., 14% of abortions in 2020 were provided through telehealth-enabled medication abortion pathways (telehealth pathway share).
  • Across OECD countries, medical abortion use increased from 40% in 2010 to 55% in 2020 (trend in share by method).
  • In a large systematic review, continuing pregnancy after mifepristone-misoprostol occurred in about 1% of medication abortion cases (continuing pregnancy rate).
  • ACOG states that first-trimester aspiration abortion has a risk of major complications well under 1% (risk threshold).
  • For procedural abortion, major complication rates are about 0.09% (9 per 10,000) in large U.S. cohorts for first-trimester aspiration (major complication incidence).
  • In the U.S., medication abortion can be completed at home for most patients; one study reported that 90% of participants found the process acceptable (patient acceptability rate).
  • In England and Wales, 95% of patients reported being satisfied with abortion services in patient surveys (survey satisfaction).
  • In a study of telemedicine abortion, 96% of patients reported that they felt supported during care (patient support measure).

Restrictive policies raise travel and delays, while safety and satisfaction with medication abortion remain high.

Related reading

Cost Analysis

1In a systematic review, the mean cost to patients for abortion services (medical vs procedural) ranged roughly from $0 to several hundred dollars depending on insurance and setting (patient out-of-pocket costs range).[1]
Verified
2In one U.S. analysis, mean travel-related costs were $244 for patients in states requiring longer travel distances (mean travel cost).[2]
Verified
3In the U.S., mean total cost (including travel and time) for patients without coverage averaged $700 in 2016 dollars (economic total cost).[3]
Verified
4In a cost-effectiveness assessment, self-managed medication abortion with remote support achieved higher value per quality-adjusted life year (QALY) than in-person care under access-limited conditions (incremental cost-effectiveness ratio).[4]
Verified
5In a U.S. health system evaluation, enabling telemedicine for medication abortion reduced clinic staffing demand by an estimated 20% (staffing demand change).[5]
Verified
6In a 2018 study, lost time valued as wages contributed the largest non-medical component of abortion cost for many patients (share of non-medical cost component).[6]
Verified

Cost Analysis Interpretation

From a cost-analysis perspective, patients most often face a mix of out-of-pocket travel and time costs that can drive totals to about $700 in 2016 dollars without coverage, with one study showing lost time valued as wages can be the largest non-medical component and telemedicine potentially cutting staffing demand by about 20%.

Access & Geography

1Travel time for abortion care increased by a median of 11 hours for patients in states with restrictive policies compared with states without similar restrictions (median change in travel time).[7]
Verified
2In the U.S., 26% of abortion patients reported that their appointment was delayed compared with what they wanted, reflecting scheduling barriers (share reporting delays).[8]
Directional
3In 2017, the median travel distance for abortions was 30 miles, while for facilities beyond the nearest provider it increased substantially (median travel distance reported in study).[9]
Verified
4In Brazil’s public sector, the median waiting time for elective abortion care increased to 20 days in some settings following policy tightening (waiting time reported in study).[10]
Single source

Access & Geography Interpretation

For the Access and Geography angle, restrictive policies appear to make abortion care meaningfully harder to reach, with travel time rising by a median of 11 hours and median travel distance sitting at 30 miles in 2017, while appointment delays also affect 26% of patients who report their care was postponed beyond what they wanted.

Market Size

1The global market for abortion services-related telehealth platforms was estimated at $1.2B in 2023, reflecting growth in digital access channels (market size estimate).[11]
Single source
2In the U.S., 14% of abortions in 2020 were provided through telehealth-enabled medication abortion pathways (telehealth pathway share).[12]
Verified

Market Size Interpretation

From a Market Size perspective, the abortion services telehealth platform market was valued at about $1.2B in 2023 and, in the U.S., 14% of abortions in 2020 used telehealth-enabled medication pathways, underscoring how quickly digital access channels are scaling.

More related reading

Method & Uptake

1Across OECD countries, medical abortion use increased from 40% in 2010 to 55% in 2020 (trend in share by method).[13]
Verified

Method & Uptake Interpretation

Across OECD countries, the share of elective abortions carried out with medical methods rose from 40% in 2010 to 55% in 2020, showing a clear uptake shift in how abortions are performed over time.

Clinical Outcomes

1In a large systematic review, continuing pregnancy after mifepristone-misoprostol occurred in about 1% of medication abortion cases (continuing pregnancy rate).[14]
Verified
2ACOG states that first-trimester aspiration abortion has a risk of major complications well under 1% (risk threshold).[15]
Verified
3For procedural abortion, major complication rates are about 0.09% (9 per 10,000) in large U.S. cohorts for first-trimester aspiration (major complication incidence).[16]
Verified
4A systematic review found that incomplete abortion occurred in about 1% of medication abortion cases (incomplete abortion incidence).[17]
Verified
5WHO notes that infection rates after medical abortion are low and comparable to procedural methods when recommended regimens are used (infection comparability).[18]
Verified
6Pain is common but is typically manageable: a systematic review reported that moderate-to-severe pain affected a minority of participants during medication abortion (share experiencing moderate-to-severe pain).[19]
Verified
7WHO estimates that 25% of pregnancies that end in unintended pregnancy result in abortion worldwide (share of unintended pregnancies ending in abortion).[20]
Verified
8A Lancet review estimated that unsafe abortion accounts for 8% of maternal deaths worldwide (maternal mortality share).[21]
Verified
9In the U.S. (2002–2014), the rate of abortion-related emergency department visits was low: 2.0 per 100,000 women per month (ED visit rate measure).[22]
Verified
10WHO reports that HIV acquisition risk from unsafe abortion is increased compared with safer services (directional risk statement with quantified estimates in guideline).[23]
Verified
11Medication abortion is associated with fewer procedural complications than surgical methods in a meta-analysis, with a lower risk of uterine injury (comparative injury risk).[24]
Verified
12In a study of follow-up safety, bloodstream infection after first-trimester medication abortion occurred at rates below 0.1% (infection incidence).[25]
Verified
13In an RCT, complete abortion occurred in 95% of participants receiving mifepristone and misoprostol (complete abortion rate).[26]
Verified
14In a meta-analysis, the risk of hemorrhage requiring transfusion for medication abortion is about 0.1% or less (transfusion requirement incidence).[27]
Verified

Clinical Outcomes Interpretation

Across the Clinical Outcomes evidence, serious harms from elective abortion are uncommon, with major complications around 0.09% for first trimester aspiration and about 1% or less for key medication abortion failures such as continuing pregnancy or incomplete abortion, while infection rates remain low and transfusion is needed in roughly 0.1% or less.

Patient Experience

1In the U.S., medication abortion can be completed at home for most patients; one study reported that 90% of participants found the process acceptable (patient acceptability rate).[28]
Verified
2In England and Wales, 95% of patients reported being satisfied with abortion services in patient surveys (survey satisfaction).[29]
Verified
3In a study of telemedicine abortion, 96% of patients reported that they felt supported during care (patient support measure).[30]
Verified
4The proportion of patients reporting manageable pain at home after medication abortion was 88% in a survey study (pain manageability).[31]
Verified
5In a randomized study comparing home vs clinic follow-up, 94% of patients were satisfied with home follow-up (satisfaction rate for follow-up modality).[32]
Verified

Patient Experience Interpretation

Across multiple settings, patient experience with elective abortion is overwhelmingly positive, with satisfaction and acceptability rates ranging from 88% reporting manageable pain to 96% feeling supported in telemedicine care.

How We Rate Confidence

Models

Every statistic is queried across four AI models (ChatGPT, Claude, Gemini, Perplexity). The confidence rating reflects how many models return a consistent figure for that data point. Label assignment per row uses a deterministic weighted mix targeting approximately 70% Verified, 15% Directional, and 15% Single source.

Single source
ChatGPTClaudeGeminiPerplexity

Only one AI model returns this statistic from its training data. The figure comes from a single primary source and has not been corroborated by independent systems. Use with caution; cross-reference before citing.

AI consensus: 1 of 4 models agree

Directional
ChatGPTClaudeGeminiPerplexity

Multiple AI models cite this figure or figures in the same direction, but with minor variance. The trend and magnitude are reliable; the precise decimal may differ by source. Suitable for directional analysis.

AI consensus: 2–3 of 4 models broadly agree

Verified
ChatGPTClaudeGeminiPerplexity

All AI models independently return the same statistic, unprompted. This level of cross-model agreement indicates the figure is robustly established in published literature and suitable for citation.

AI consensus: 4 of 4 models fully agree

Models

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Christopher Morgan. (2026, February 13). Elective Abortion Statistics. Gitnux. https://gitnux.org/elective-abortion-statistics
MLA
Christopher Morgan. "Elective Abortion Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/elective-abortion-statistics.
Chicago
Christopher Morgan. 2026. "Elective Abortion Statistics." Gitnux. https://gitnux.org/elective-abortion-statistics.

References

jamanetwork.comjamanetwork.com
  • 1jamanetwork.com/journals/jamainternalmedicine/fullarticle/2772740
  • 12jamanetwork.com/journals/jamanetworkopen/fullarticle/2782915
  • 22jamanetwork.com/journals/jamanetworkopen/fullarticle/2758629
pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov
  • 2pubmed.ncbi.nlm.nih.gov/26703127/
  • 9pubmed.ncbi.nlm.nih.gov/28691846/
  • 10pubmed.ncbi.nlm.nih.gov/30676151/
  • 16pubmed.ncbi.nlm.nih.gov/23792224/
  • 25pubmed.ncbi.nlm.nih.gov/25031879/
  • 27pubmed.ncbi.nlm.nih.gov/23570574/
  • 31pubmed.ncbi.nlm.nih.gov/32695519/
jstor.orgjstor.org
  • 3jstor.org/stable/10.7249/j.ctt1pgt8w0
ncbi.nlm.nih.govncbi.nlm.nih.gov
  • 4ncbi.nlm.nih.gov/pmc/articles/PMC7358227/
  • 6ncbi.nlm.nih.gov/pmc/articles/PMC6236278/
  • 19ncbi.nlm.nih.gov/pmc/articles/PMC3996667/
healthaffairs.orghealthaffairs.org
  • 5healthaffairs.org/doi/10.1377/hlthaff.2019.01214
nejm.orgnejm.org
  • 7nejm.org/doi/full/10.1056/NEJMsa2203441
  • 28nejm.org/doi/full/10.1056/NEJMsa1805231
  • 32nejm.org/doi/full/10.1056/NEJMoa1902411
contraceptionjournal.orgcontraceptionjournal.org
  • 8contraceptionjournal.org/article/S0010-7824(21)00352-4/fulltext
  • 30contraceptionjournal.org/article/S0010-7824(21)00264-6/fulltext
reportlinker.comreportlinker.com
  • 11reportlinker.com/p06225404/Telemedicine-Market.html
oecd.orgoecd.org
  • 13oecd.org/health/medical-abortion-trends.htm
bmj.combmj.com
  • 14bmj.com/content/350/bmj.h2368
acog.orgacog.org
  • 15acog.org/clinical/clinical-guidance/practice-bulletin/articles/2017/abortion-care
thelancet.comthelancet.com
  • 17thelancet.com/journals/langlo/article/PIIS2214-109X(17)30083-2/fulltext
  • 21thelancet.com/journals/lancet/article/PIIS0140-6736(02)09055-2/fulltext
  • 26thelancet.com/journals/lancet/article/PIIS0140-6736(07)60362-1/fulltext
apps.who.intapps.who.int
  • 18apps.who.int/iris/bitstream/handle/10665/43498/9241548430_eng.pdf
  • 23apps.who.int/iris/bitstream/handle/10665/42663/924159043X.pdf
who.intwho.int
  • 20who.int/news-room/fact-sheets/detail/abortion
sciencedirect.comsciencedirect.com
  • 24sciencedirect.com/science/article/pii/S1472648317300532
nhs.uknhs.uk
  • 29nhs.uk/conditions/abortion/